DeepMed Research

National Institute of Mental Health, Dhaka

🇧🇩Bangladesh

Country: 🇧🇩Bangladesh

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Emotional, Social, Cognitive and Behavioral Sequalae of the COVID-19 Pandemic

Completed

Conditions: Healthy Volunteer

First Posted Date: 2021-04-01

Last Posted Date: 2025-05-01

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 2086

Registration Number: NCT04823988

Locations: 🇺🇸
National Institute of Mental Health (NIMH), Bethesda, Maryland, United States

Antidepressant Effects of TS-161 in Treatment-Resistant Depression

Phase 2

Completed

Conditions: Major Depressive Disorder
Treatment-Resistant Depression
Depression

Interventions: Other: Placebo
Drug: TS-161 (50 - 100 mg)

First Posted Date: 2021-03-29

Last Posted Date: 2024-07-24

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 11

Registration Number: NCT04821271

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Not Applicable

Recruiting

Conditions: Autism Spectrum Disorder

Interventions: Device: Continuous Theta Burst Stimulation

First Posted Date: 2021-03-15

Last Posted Date: 2025-05-21

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 106

Registration Number: NCT04798274

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine

Phase 1

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: (2R,6R)-Hydroxynorketamine hydrochloride
Drug: Placebo

First Posted Date: 2021-01-15

Last Posted Date: 2024-06-06

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 74

Registration Number: NCT04711005

Locations: 🇺🇸
Duke Early Phase Clinical Research, Durham, North Carolina, United States

Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen

Completed

Conditions: Depression
Anxiety
Bipolar Disorder

First Posted Date: 2020-12-24

Last Posted Date: 2025-05-18

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 193

Registration Number: NCT04684615

Locations: 🇺🇸
National Institute of Mental Health (NIMH), Bethesda, Maryland, United States

Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations

Recruiting

Conditions: Children With Neurodevelopmental Disorders
Children With Neuropsychiatric Disorders
Healthy Children
Children With Behavioral Syndromes

First Posted Date: 2020-11-23

Last Posted Date: 2025-05-20

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 244

Registration Number: NCT04639830

Locations: 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸
Geisinger Medical Center, Danville, Pennsylvania, United States
🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

and more 2 locations

Developing Brain, Impulsivity and Compulsivity

Recruiting

Conditions: Conduct Disorder
Obsessive Compulsive Disorder
Typical Development
Attention Deficit Hyperactivity Disorder

First Posted Date: 2020-11-17

Last Posted Date: 2025-03-11

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 1100

Registration Number: NCT04631042

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)

Phase 1

Recruiting

Conditions: Depression

Interventions: Drug: 11C-MCI
Drug: 11CPS13

First Posted Date: 2020-10-12

Last Posted Date: 2025-04-04

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 64

Registration Number: NCT04582916

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Phase 1

Recruiting

Conditions: Parkinson's Disease
Dementia
Alzheimer's Disease
ALS
Mild Cognitive Impairment

Interventions: Drug: 11C-MC1
Drug: 11C-PS13
Drug: 18f-florbetaben

First Posted Date: 2020-05-21

Last Posted Date: 2025-03-18

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 168

Registration Number: NCT04396873

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses

Completed

Conditions: Anxiety
Healthy Volunteers

Interventions: Behavioral: Computer task questionnaires

First Posted Date: 2020-05-06

Last Posted Date: 2023-06-07

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 2962

Registration Number: NCT04377100

Locations: 🇺🇸
National Institute of Mental Health (NIMH), Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy